Virological and Pharmaceutical Properties of Clinically Relevant Phages
Open Access
- 10 May 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (5) , 487
Abstract
As antimicrobial resistance continues to undermine the efficacy of antibiotics, the global medical community is increasingly turning to alternative treatment modalities. Among these, phage therapy has re-emerged as a promising strategy for managing multidrug-resistant bacterial infections. Herein, we present and briefly discuss eight essential attributes of clinically relevant phages for therapy, which may be categorized broadly into virological and pharmacological characteristics. Virological attributes include a broad host range, a strictly lytic life cycle and the ability to manage the emergence of bacterial resistance to phages. Comprehensive genomic and proteomic characterization forms the foundation for selecting and engineering such candidates, ensuring both safety and predictability. From a pharmacological standpoint, phages should ideally show safety across relevant formulations and routes of administration, favorable pharmacokinetics, stability during storage and scalability in manufacturing. Advances in genomic analysis, artificial intelligence-driven phage selection and formulation technologies have further accelerated the translational potential of phage therapy. By systematically addressing each of these critical attributes, this work aims to inform the rational selection and development of therapeutic phages suitable for integration into the clinical practice.Keywords
This publication has 57 references indexed in Scilit:
- Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeuticsBiologicals, 2023
- Long‐Read Sequencing Reveals Extensive DNA Methylations in Human Gut Phagenome Contributed by Prevalently Phage‐Encoded MethyltransferasesAdvanced Science, 2023
- Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translationClinical Microbiology and Infection, 2023
- Approaches for manufacture, formulation, targeted delivery and controlled release of phage-based therapeuticsCurrent Opinion in Biotechnology, 2021
- Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infectionsVirus Genes, 2020
- Virome: The Prodigious Little Cousin of the Family2020
- Reprogramming Bacteriophage Host Range through Structure-Guided Design of Chimeric Receptor Binding ProteinsCell Reports, 2019
- Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse ModelCell Host & Microbe, 2019
- Formulation, stabilisation and encapsulation of bacteriophage for phage therapyAdvances in Colloid and Interface Science, 2017
- Bacteriophage-encoded depolymerases: their diversity and biotechnological applicationsApplied Microbiology and Biotechnology, 2016